Small molecular inhibitors for KRAS-mutant cancers

Overview of attention for article published in Frontiers in immunology, August 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 30 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 34,597 followers.

Frontiers | Small molecular inhibitors for KRAS-mutant cancers https://t.co/rfcdRHqIIk

28 Aug 2023

Reply Repost Favourite

RT @FrontImmunol: New Research: Small molecular inhibitors for KRAS-mutant cancers: Three rat sarcoma (RAS) gene isoforms, KRAS, NRAS, and…

19 Aug 2023

Reply Repost Favourite

RT @FrontImmunol: New Research: Small molecular inhibitors for KRAS-mutant cancers: Three rat sarcoma (RAS) gene isoforms, KRAS, NRAS, and…

19 Aug 2023

Reply Repost Favourite

New Research: Small molecular inhibitors for KRAS-mutant cancers: Three rat sarcoma (RAS) gene isoforms, KRAS, NRAS, and HRAS, constitute the most mutated family of small GTPases in cancer. While the development of targeted immunotherapies… #immunology htt

19 Aug 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.